WHO primates, vaccines, and conservation
The 1971 WHO primate report tied vaccine science to zoonotic risk, exporting-country blame, and captive breeding.
Source
Nonhuman Primates in Public Health: Between Biological Standardization, Conservation and Care
What they did
The article reconstructs Technical Report 470 and the Berne symposium, reading WHO drafts, stakeholder replies, and IUCN conservation talk.
What they found
Marburg and wild-primate trade forced the WHO to treat animal health as public health. Hazardous primates were located in exporting countries. Captive breeding was sold as better animals and a way to keep imports until colonies existed.
The limits
What it doesn't show
This is a history of WHO technical politics, not a virology paper or a census of today’s primate trade.
Key terms
- Technical Report 470
- 1971 WHO scientific-group report on health aspects of supplying and using nonhuman primates.
- Marburg virus
- 1967 lab outbreak linked to African green monkeys that pushed the WHO toward zoonotic primate risk.
- Captive breeding
- WHO-endorsed alternative to wild capture, framed as producing superior laboratory animals.
- Biological standardization
- Vaccine and lab-animal quality regimes that made primate supply a public-health infrastructure problem.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
The 1971 Berne meeting was about?
Common questions
Why did animal health become a WHO issue?
Vaccine work and wild-primate circulation created zoonotic and supply crises.
Where was the ‘hazard’ located?
In exporting countries’ trapping, housing, and care, not in importing labs alone.
Why conservation?
To keep wild imports flowing until breeding colonies existed, and to avoid embargoes.
More on Public health